Societal CDMO

About Societal CDMO

Societal CDMO (NASDAQ: SCTL) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal CDMO is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, packaging and logistics services to the global pharmaceutical market.

  • US
  • 2017
    On CPHI since
  • 100 - 249
Company types
Contact info
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024

Societal CDMO Resources (2)

  • News Recro eyes expansion to full-service CDMO status

    The solid oral dose specialist signs letter of intent for acquisition of a CDMO providing a full range of services
  • Video Recro Facility Video

    When you choose to work with Recro, you’ll find a project team with extensive industry experience, many of whom are Ph.D. level scientists who will make sure you’re fully informed at every stage of your project and give you the worry-free confidence your product plan is on track. Our tenure and reputation for success enable us to produce the products that get you to the next level. Elevate your expectations beyond the ordinary. Let Recro deliver excellence.